Mental slowness and executive dysfunctions in patients with metabolic syndrome

Neuroscience Letters

Volumn 462, Issue 1, 2009, Pages 49-53

  Segura, Bàrbara ^a   Jurado, María Ángeles ^a,e   Freixenet, Núria ^b   Albuin, Carlota ^c   Muniesa, Jesús ^d   Junqué, Carme ^a,f  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL DE SABADELL   (Spain)

^c Centre d'atenció primària Canaletes   (Spain)

^d Centre d'atenció primària de Sant Just Desvern   (Spain)

^e Institute for Brain Cognition and Behavior (IR3C)   (Spain)

^f INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Ageing; Cerebrovascular disease; Cognition; Metabolic syndrome X; Neuropsychological assessment; Risk factors

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; LANGUAGE ABILITY; LANGUAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MENTAL PERFORMANCE; METABOLIC SYNDROME X; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; SHORT TERM MEMORY; VERBAL MEMORY; WORKING MEMORY;

COGNITION; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MENTAL PROCESSES; METABOLIC SYNDROME X; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEX FACTORS;

EID: 67650743981     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.06.071     Document Type: Article

References (32)

1. Abbatecola A.M., Paolisso G., Lamponi M., Bandinelli S., Lauretani F., Launer L., and Ferrucci L. Insulin resistance and executive dysfunction in older persons. J. Am. Geriatr. Soc. 52 (2004) 1713-1718
2. Alberti G. Introduction to the metabolic syndrome. Eur. Heart J. Suppl. 7 Suppl_D (2005) D3-D5
3. Bang O.Y., Kim J.W., Lee J.H., Lee M.A., Lee P.H., Joo I.S., and Huh K. Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 26 (2005) 296-298
4. Dik M.G., Jonker C., Comijs H.C., Deeg D.J., Kok A., Yaffe K., and Penninx B.W. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care 30 (2007) 2655-2660
5. Elias M.F., Sullivan L.M., D'Agostino R.B., Elias P.K., Beiser A., Au R., DeCarli C., and Wolf P.A. Framingham stroke risk profile and lowered cognitive performance. Stroke 35 (2004) 404-409
6. Field A. Discovering Statistics Using SPSS. Second edition (2005), Sage, London
7. a ed. (1999), Masson, Barcelona
8. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., Gordon D.J., Krauss R.M., Savage P.J., Smith S.C., Spertus J.A., and Costa F. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 25 (2005) 2735-2752
9. Ingles J.L., Boulton D.C., Fisk J.D., and Rockwood K. Preclinical vascular cognitive impairment and Alzheimer disease: neuropsychological test performance 5 years before diagnosis. Stroke 38 (2007) 1148-1153
10. Isomaa B., Almgren P., Tuomi T., Forsen B., Lahti K., Nissen M., Taskinen M.R., and Groop L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
11. Kalmijn S., Foley D., White L., Burchfiel C.M., Curb J.D., Petrovitch H., Ross G.W., Havlik R.J., and Launer L.J. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia aging study. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2255-2260
12. Kaplan N.M. The deadly quartet, upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch. Intern. Med. 149 (1989) 1514-1520
13. Kawamoto R., Tomita H., Ohtsuka N., Inoue A., and Kamitani A. Metabolic syndrome, diabetes and subclinical atherosclerosis as assessed by carotid intima-media thickness. J. Atheroscler. Thromb. 14 (2007) 78-85
14. Kennedy K.M., and Raz N. Aging white matter and cognition: differential effects of regional variations in diffusion properties on memory, executive functions, and speed. Neuropsychologia 47 (2009) 916-927
15. Kivipelto M., Ngandu T., Fratiglioni L., Viitanen M., Kareholt I., Winblad B., Helkala E.L., Tuomilehto J., Soininen H., and Nissinen A. Obesity and vascular risk factors at midlife and the risk of dementia and alzheimer disease. Arch. Neurol. 62 (2005) 1556-1560
16. Laudisio A., Marzetti E., Pagano F., Cocchi A., Franceschi C., Bernabei R., and Zuccala G. Association of metabolic syndrome with cognitive function: the role of sex and age. Clin. Nutr. 27 (2008) 747-754
17. Lemieux I., Pascot A., Couillard C., Lamarche B., Tchernof A., Almeras N., Bergeron J., Gaudet D., Tremblay G., Prud'homme D., Nadeau A., and Despres J.P. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 11 (2000) 179-184
18. Lezak M.D., Howieson D.B., and Loring D.W. Neuropsychological Assessment. 3rd ed. (2004), Oxford University Press, New York
19. Nicolson G.L. Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function. J. Cell Biochem. 15 (2007) 1352-1369
20. Nordlund A., Rolstad S., Klang O., Lind K., Hansen S., and Wallin A. Cognitive profiles of mild cognitive impairment with and without vascular disease. Neuropsychology 21 (2007) 706-712
21. O'Brien J.T., Erkinjuntti T., Reisberg B., Roman G., Sawada T., Pantoni L., Bowler J.V., Ballard C., DeCarli C., Gorelick P.B., Rockwood K., Burns A., Gauthier S., and DeKosky S.T. Vascular cognitive impairment. Lancet Neurol. 2 (2003) 89-98
22. Reaven G.M. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus. Diabetes Metab. Rev. 9 Suppl 1 (1993) 5S-12S
23. Reitz C., Luchsinger J., Tang M.X., Manly J., and Mayeux R. Impact of plasma lipids and time on memory performance in healthy elderly without dementia. Neurology 26 (2005) 1378-1383
24. a ed. (2007), Masson, Barcelona
25. Roriz-Cruz M., Rosset I., Wada T., Sakagami T., Ishine M., De Sa Roriz-Filho J., Cruz T.R., Hosseinkhani M., Rodrigues R.P., Sudoh S., Arai H., Wakatsuki Y., Souza A.C., Nakagawa M., Kita T., and Matsubayashi K. Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol. Aging 28 (2007) 1723-1736
26. Sachdev P.S., Brodaty H., Valenzuela M.J., Lorentz L., Looi J.C., Wen W., and Zagami A.S. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 23 (2004) 912-919
27. Segura B., Jurado M.A., Freixenet N., Falcón C., Junqué C., and Arboix A. White matter changes in metabolic syndrome patients: a diffusion tensor imaging study. Neurology 73 (2009) in press
28. van den Berg E., Biessels G.J., de Craen A.J., Gussekloo J., and Westendorp R.G. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology 69 (2007) 979-985
29. van den Berg E., Dekker J.M., Nijpels G., Kessels R.P., Kappelle L.J., de Haan E.H., Heine R.J., Stehouwer C.D., and Biessels G.J. Cognitive functioning in elderly persons with type 2 diabetes and metabolic syndrome: the hoorn study. Dement. Geriatr. Cogn. Disord. 26 (2008) 261-269
30. Vanhanen M., Koivisto K., Moilanen L., Helkala E.L., Hanninen T., Soininen H., Kervinen K., Kesaniemi Y.A., Laakso M., and Kuusisto J. Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 67 (2006) 843-847
31. Vicario A., Martinez C.D., Baretto D., Diaz Casale A., and Nicolosi L. Hypertension and cognitive decline: impact on executive function. J. Clin. Hypertens. (Greenwich) 7 (2005) 598-604
32. Yaffe K., Haan M., Blackwell T., Cherkasova E., Whitmer R.A., and West N. Metabolic syndrome and cognitive decline in elderly latinos: findings from the Sacramento area latino study of aging study. J. Am. Geriatr. Soc. 55 (2007) 758-762